Company: NBRG
Filing Date: 2025-08-29
Form Type: S-1
Source: 0001213900-25-082694
Chunk: 185

Company: Newbridge Acquisition Ltd
Filing Date: 2025-08-29
Form: S-1
Chunk 185
---
 on our behalf. The loan is, at the discretion of the sponsor, due on the consummation of this offering. Each promissory note will be payable without interest. Each promissory note will be repaid out of the proceeds of this offering available to us for payment of offering expenses. Our initial shareholders have committed to purchase from us an aggregate of 175,000 private units (or up to 186,250 private units if the underwriters’ over -allotmentoption is exercised in full) at $10.00 per unit. Such purchases will take place on a private placement basis simultaneously with the consummation of this offering. All of the proceeds we receive from the purchase of the private units will be placed in the trust account described below. We do not believe we will need to raise additional funds following this offering in order to meet the expenditures required for operating our business. However, in order to finance transaction costs in connection with an intended initial business combination, our initial shareholders, officers, directors or their affiliates may, but are not obligated to, loan us funds as may be required. Such loans would be evidenced by promissory notes. In the event that we are unable to consummate an initial business combination, we may use a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from our trust account would be used for such repayment. If we consummate an initial business combination, the notes would either be paid upon consummation of our initial business combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the notes may be converted upon consummation of our business combination into additional private units at a price of $10.00 per unit (which, for example, would result in the holders being issued 150,000 units if the full amount of notes were issued and converted). In connection with this transaction, we have agreed to issue 150,000 Class A ordinary shares as representative shares (or 186,250 representative shares if the underwriters exercise their over -allotmentoption in full) to the underwriters. The holders of the representative shares have agreed (A) to vote the representative shares in favor of any proposed business combination, (B) not to convert representative shares in connection with a shareholder vote to approve a proposed initial business combination or sell the representative shares to us in a tender offer in connection with a proposed initial business combination and (C) that the representative shares will not participate